Nutraceuticals, health supplements, foods for special dietary use, foods for special medical purpose, and prebiotic and probiotic foods sit under a dedicated set of FSSAI regulations notified in 2016 and amended since. They are food products in law, which means FSSAI licenses them and CDSCO does not.
That single fact saves a lot of wasted effort. Every month we speak to a founder who has been told they need a drug licence for a protein powder or a multivitamin. They do not. What they need is an FSSAI licence with the correct nutraceutical categories endorsed, and a plant that satisfies Schedule IV.
Where projects actually fail
In our experience two issues account for most delayed or rejected supplement projects, and neither of them is the application form.
1. Ingredient eligibility
Every vitamin, mineral, amino acid, botanical extract, enzyme and probiotic strain used in a supplement has to be traceable to the schedules of the 2016 regulations, and used within the permitted levels. An ingredient outside those lists is not automatically prohibited, but it requires a separate approval route that takes considerably longer than the licence itself.
The expensive version of this mistake looks like this: a brand finalises a formulation with a contract R&D lab, prints artwork, books a launch date, and only then discovers that one botanical in the blend is not listed, or that the vitamin D level is above the permitted maximum for the category. Reformulating at that point means new stability data, new artwork, and a launch pushed by a quarter.
Screen the formulation before anything else. It takes a week and it is the cheapest week in the project.
2. Schedule IV good manufacturing practice
Schedule IV governs how the plant is built and run: segregation of areas, air handling appropriate to the dosage form, personnel and material flow, change room sequencing, water systems, equipment cleaning, in-process controls and records.
The requirements differ meaningfully by dosage form. A dry powder blending and packing line is not the same problem as a softgel line, which is not the same as a liquid shot line. Plants designed to a generic template usually have to be modified after the first inspection, and modification after commissioning is several times the cost of designing it correctly.
Categories are not interchangeable
The 2016 regulations cover several distinct categories, and they carry different rules on composition, dosage form, labelling and claims:
- Health supplements are intended to supplement the normal diet, in measured unit doses.
- Nutraceuticals are products with a physiological benefit, again in measured doses.
- Food for special dietary use is formulated for particular dietary requirements.
- Food for special medical purpose is intended for dietary management under medical supervision, and carries the strictest requirements of the group.
- Prebiotic and probiotic foods have their own strain and viability requirements.
Placing a product in the wrong category produces a licence that does not match the label, which is the sort of discrepancy an inspector notices immediately and a customs officer notices on import.
Claims decide your category as much as composition does
A product that claims to treat, prevent or cure a disease is a drug, regardless of what is in it. Supplement marketing routinely drifts towards therapeutic language, and the drift is usually introduced by a marketing agency well after the regulatory work is finished.
The safe practice is to vet claims at the formulation stage, against the Advertising and Claims Regulations, and to keep the substantiation for each claim on file. Rewriting a claim into compliant language is easy at artwork stage and painful after a notice.
A realistic sequence
- Formulation screening against permitted ingredient lists and levels, per SKU. One to two weeks.
- Category and claim positioning, fixing the regulatory category and vetting proposed claims. Under a week.
- Layout and Schedule IV readiness, designed for the dosage forms in scope. Two to four weeks of design, then construction.
- Licence application on FoSCoS with nutraceutical categories endorsed and the full technical annexure set.
- Inspection support and grant.
Run steps three and four in parallel rather than in sequence. The licence is granted against a ready premises, so there is no benefit to finishing the building before the paperwork starts, and there is a real cost to finishing the paperwork months after the machinery is installed and idle.
If you are planning a supplement plant, send us the product list and we will tell you what the formulation and the facility will each need before you commit capital to either.